Detection of specific IgE antibodies in sera of Japanese birch-allergic patients using recombinant allergens Bet v 1, Bet v 2 and Bet v 4

Allergology International

Volumn 57, Issue 1, 2008, Pages 93-96

  Shirasaki, Hideaki ^a,c   Yamamoto, Tetsuo ^b   Koyanagi, Yoko ^a   Watanabe, Naoki ^a   Himi, Tetsuo ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Yamamoto ENT Clinic   (Japan)

^c SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Bet v 1; Bet v 2; Birch pollinosis; RAST

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; RECOMBINANT ALLERGEN;

ADULT; ALLERGY; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN SPECIFICITY; ARTICLE; BIRCH; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOREACTIVITY; MALE; MEDICAL DOCUMENTATION; POLLEN ALLERGY; PRIORITY JOURNAL; RADIOALLERGOSORBENT TEST;

EID: 40949160665     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.O-07-502     Document Type: Article

References (12)

1. Breiteneder H, Pettenburger K, Bito A et al. The gene coding for the major birch pollen allergen, Bet v 1, is highly homologous to a pea disease resistance response gene. EMBO J. 1989;8:1935-1938.
2. Valenta R, Duchene M, Pettenburger K et al. Identification of profiling as a novel pollen allergen: IgE autoreactivity in sensitized individuals. Science 1991;253:557-560.
3. Twardosz A, Hayek B, Seiberler S et al. Molecular characterization, expression in Escherichia coli, and epitope analysis of a two EF-hand calcium-binding birch pollen allergen, Bet v 4. Biochem. Biophys. Res. Commun. 1997;239:197-204.
4. Engel E, Richter K, Obermeyer G et al. Immunological and biological properties of Bet v 4, a novel birch pollen allergen with two EF-hand calcium-binding domains. J. Biol. Chem. 1997;272:28630-28637.
5. Moverare R, Westritschnig K, Svensson M et al. Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations: An imprint of local sensitization. Int. Arch. Allergy Immunol. 2002;128:325-335.
6. Rossi RE, Monasterolo G, Monasterolo S. Detection of specific IgE antibodies in the sera of patients allergic to birch pollen using recombinant allergen Bet v 1, Bet v 2, Bet v 4: evaluation of different IgE reactivity profiles. Allergy 2003;58:929-932.
7. Shirasaki H, Narita S, Watanabe K et al. Relationship between birch pollen counts and meteorological factors for 8 years in Sapporo. Nippon Jibiinkoka Gakkai Kaiho 2003;106:705-709.
8. Ghunaim N, Grönlund H, Kronqvist M et al. Antibody profiles and self-reported symptoms to pollen-related food allergens in grass pollen-allergic patients from northern Europe. Allergy 2005;60:185-191.
9. Valenta R, Duchene M, Ebner C et al. Profilins constitute a novel family of functional plant pan allergens. J. Exp. Med. 1992;175:377-385.
10. Kazemi-Shirazi L, Niederberger V, Linhart B, Lidholm J, Kraft D, Valenta R. Recombinant marker allergens: diagnostic gatekeepers for the treatment of allergy. Int. Arch. Allergy Immunol. 2002;127:259-268.
11. Focke M, Linhart B, Hartl A et al. Non-anaphylactic surface-exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccination. Clin. Exp. Allergy 2004;34:1525-1533.
12. Gafvelin G, Thunberg S, Kronqvist M et al. Cytokine and antibody responses in birch-pollen-allergic patients treated with genetically modified derivatives of the major birch pollen allergen Bet v 1. Int. Arch. Allergy Immunol. 2005;138:59-66.